BRIEF published on 04/25/2024 at 18:05, 2 years 5 months ago PAREF financial report for the first quarter of 2024 Real Estate Financial Market Turnover Responsible Investment SCPI
PRESS RELEASE published on 04/25/2024 at 18:00, 2 years 5 months ago PAREF - INFORMATIONS FINANCIERES AU 1ER TRIMESTRE 2024 Le chiffre d'affaires consolidé du Groupe PAREF au 1er trimestre 2024 s'élève à 6,8 M€, en baisse de -24% par rapport à 2023. Diversification des revenus grâce aux commissions de gestion et de souscription Chiffre D'affaires Consolidé Groupe PAREF Commissions De Gestion Diversification Des Revenus Réduction De -24%
PRESS RELEASE published on 04/25/2024 at 18:00, 2 years 5 months ago PAREF - FINANCIAL INFORMATION FIRST QUARTER 2024 PAREF Group reports consolidated revenue of €6.8 Mn in Q1 2024, down by 24% YoY. Revenue comprises rental income, management commissions, & subscription commissions. Company's diversified activities contributed to revenue stability Consolidated Revenue Q1 2024 PAREF Group Revenue Breakdown Business Diversification
Published on 10/12/2026 at 22:01, 8 hours 11 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 15 hours 12 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 17 hours 12 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 3 days 1 hour ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 3 days 4 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/13/2026 at 06:00, 12 minutes ago Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA
Published on 10/12/2026 at 20:30, 9 hours 42 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 9 hours 42 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 10 hours 6 minutes ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 17:59, 12 hours 12 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 12 hours 12 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
Published on 10/12/2026 at 17:45, 12 hours 27 minutes ago Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 11/10/2026
Published on 10/12/2026 at 17:45, 12 hours 27 minutes ago Déclaration hebdomadaire de rachat d'actions
